B026
B026 is a selective, potent, orally active p300/CBP histone acetyltransferase (HAT) inhibitor with IC50 values of 1.8 nM and 9.5 nM for p300 and CBP enzyme, respectively. B026 has anticancer activity for androgen receptor-positive (AR+) prostate cancer cell lines[1].
Product Specifications
CAS Number
2379416-48-3
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/b026.html
Solubility
10 mM in DMSO
Smiles
O=C1[C@@]2(NC(N1CC(N3[C@@H](COC4=CC=C(F)C=C4C3)C(F)(F)F)=O)=O)C5=CC=C(C6=CN(N=C6)C)C=C5CC2
Molecular Formula
C27H23F4N5O4
Molecular Weight
557.50
References & Citations
[1]Yang Y, et, al. Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors. J Med Chem. 2020 Feb 13;63 (3) :1337-1360.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681675-100 1x 100 µL
Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details